Back to top

Analyst Reiterates Buy on Sera Prognostics, Citing Expanding Payer Coverage and Large Long???Term Market Opportunity

TD Cowen analyst Daniel Brennan has maintained their bullish stance on SERA stock, giving a Buy rating today. Daniel Brennan has given his Buy rati...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Sera Prognostics, Inc. (SERA)